|
Serum interleukin 8 (IL-8) may serve as a biomarker of response to immuno-oncology (I-O) therapy. |
| |
|
No Relationships to Disclose |
| |
|
Employment - Bristol-Myers Squibb |
Stock and Other Ownership Interests - Bristol-Myers Squibb |
| |
|
Employment - Bristol-Myers Squibb |
Stock and Other Ownership Interests - Bristol-Myers Squibb |
| |
|
Employment - Bristol-Myers Squibb |
Stock and Other Ownership Interests - Bristol-Myers Squibb |
Research Funding - Bristol-Myers Squibb |
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb |
Other Relationship - Celgene (I) |
| |
|
Employment - Bristol-Myers Squibb |
Stock and Other Ownership Interests - Bristol-Myers Squibb |
| |
|
Employment - Bristol-Myers Squibb |
Stock and Other Ownership Interests - Bristol-Myers Squibb |
| |
|
Employment - Bristol-Myers Squibb |
Stock and Other Ownership Interests - Bristol-Myers Squibb |
| |
|
Employment - Bristol-Myers Squibb |
Stock and Other Ownership Interests - Bristol-Myers Squibb |
| |
|
Employment - Bristol-Myers Squibb |
Stock and Other Ownership Interests - Bristol-Myers Squibb |
| |
|
Honoraria - AstraZeneca; Lilly |
Consulting or Advisory Role - Alligator Bioscience; AstraZeneca; Bayer; Bristol-Myers Squibb; Lilly; Roche; Tusk Therapeutics |
Research Funding - Bristol-Myers Squibb; Pfizer; Tusk Therapeutics |
Travel, Accommodations, Expenses - Roche |